Structures by: Velmurugan D.
Total: 407
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(4-methoxyphenyl)acetamide
C13H15N5O2S
IUCrData (2018) 3, 4 x180600
a=18.2763(6)Å b=7.5909(2)Å c=20.0571(6)Å
α=90° β=90° γ=90°
Ethyl 4-(furan-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C12H14N2O4
IUCrData (2016) 1, 12 x161937
a=7.4670(2)Å b=8.8307(3)Å c=10.5426(3)Å
α=106.833(2)° β=108.557(2)° γ=99.420(2)°
<i>N</i>-[(3-Bromo-1-phenylsulfonyl-1<i>H</i>-indol-2-yl)methyl]-4-fluoroaniline
C21H16BrFN2O2S
IUCrData (2017) 2, 2 x170147
a=8.1732(5)Å b=10.5828(7)Å c=12.1781(8)Å
α=113.6990(10)° β=94.6170(10)° γ=99.2030(10)°
2-(4-Chlorophenyl)-15-hydroxy-4-methyl-4,18-diazaoctacyclo[14.11.1.1^6,10^.0^1,5^.0^5,15^.0^17,26^.0^19,24^.0^14,29^]nonacosa-6,8,10(29),11,13,17,19(24),20,22,25-decaen-27-one methanol hemisolvate
C34H25ClN2O2,0.5(CH4O)
IUCrData (2016) 1, 4 x160637
a=10.3848(3)Å b=10.4306(3)Å c=14.4513(4)Å
α=69.3940(10)° β=72.3880(10)° γ=70.8710(10)°
6b-Hydroxy-17-methyl-15-(3-nitrophenyl)-6b,7,16,17-tetrahydro-7,14a-methanonaphtho[1',8':1,2,3]pyrrolo[3',2':8,8a]azuleno[5,6-<i>b</i>]quinolin-14(15<i>H</i>)-one dichloromethane hemisolvate
C34H25N3O4,0.5(CH2Cl2)
IUCrData (2016) 1, 5 x160828
a=9.3566(3)Å b=12.1189(4)Å c=12.7055(4)Å
α=94.490(2)° β=93.300(2)° γ=107.5540(10)°
<i>N</i>,<i>N</i>-Diethyl-2-[5-(4-methoxybenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetamide
C17H20N2O4S
IUCrData (2017) 2, 5 x170716
a=11.6978(6)Å b=7.1331(4)Å c=21.1822(12)Å
α=90° β=95.311(4)° γ=90°
1,4-Bis[(oxan-2-yl)oxy]benzene
C16H22O4
IUCrData (2017) 2, 5 x170717
a=6.767(5)Å b=6.817(5)Å c=15.864(5)Å
α=90.000° β=99.391(5)° γ=90.000°
Isonicotinamidium picrate
C12H9N5O8
RSC Adv. (2016) 6, 63 57977
a=14.290(5)Å b=7.430(5)Å c=14.697(5)Å
α=90.000(5)° β=116.638(5)° γ=90.000(5)°
C45H50Cl2CuN6O9
C45H50Cl2CuN6O9
Dalton transactions (Cambridge, England : 2003) (2016) 45, 18 7794-7814
a=16.0226(4)Å b=16.0226(4)Å c=34.0974(12)Å
α=90° β=90° γ=120°
(<i>E</i>)-4-{1-[2-(Carbamothioyl)hydrazin-1-ylidene]ethyl}phenyl 4-methylbenzoate
C17H17N3O2S
Acta Crystallographica Section E (2015) 71, 1 o43-o44
a=8.068(5)Å b=14.037(5)Å c=15.221(5)Å
α=99.801(5)° β=96.040(5)° γ=98.533(5)°
2-{[(Naphthalen-1-yl)oxy]methyl}-5-(2,4,5-trifluorophenyl)-1,3,4-oxadiazole
C19H11F3N2O2
Acta Crystallographica Section E (2015) 71, 3 o190-o191
a=7.4817(5)Å b=7.5928(5)Å c=15.7908(10)Å
α=78.673(3)° β=78.404(3)° γ=65.370(3)°
2-(4-Fluoro-3-methylphenyl)-5-{[(naphthalen-1-yl)oxy]methyl}-1,3,4-oxadiazole
C20H15FN2O2
Acta Crystallographica Section E (2015) 71, 4 o229-o230
a=7.4236(4)Å b=7.5062(4)Å c=16.3519(8)Å
α=77.092(3)° β=77.494(3)° γ=66.734(3)°
(<i>E</i>)-4-[1-(2-Carbamothioylhydrazinylidene)ethyl]phenyl acetate
C11H13N3O2S
Acta Crystallographica Section E (2017) 73, 1 20-23
a=7.8783(2)Å b=8.9254(3)Å c=18.7372(5)Å
α=77.243(2)° β=82.423(2)° γ=78.856(2)°
(<i>E</i>)-4-[1-(2-Carbamothioylhydrazinylidene)ethyl]phenyl benzoate
C16H15N3O2S
Acta Crystallographica Section E (2017) 73, 1 20-23
a=7.8145(4)Å b=9.7538(5)Å c=10.9050(7)Å
α=78.855(4)° β=69.031(2)° γ=84.200(3)°
<i>N</i>-(4-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2017) 73, 4 467-471
a=18.2743(12)Å b=7.4835(5)Å c=19.8021(12)Å
α=90° β=90° γ=90°
<i>N</i>-(3-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2017) 73, 4 467-471
a=18.220(2)Å b=8.1180(12)Å c=19.628(2)Å
α=90° β=108.761(8)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(naphthalen-1-yl)acetamide
C16H15N5OS
Acta Crystallographica Section E (2017) 73, 2 306-309
a=25.1895(16)Å b=6.9411(4)Å c=8.9697(6)Å
α=90° β=90.943(4)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(4-fluorophenyl)acetamide
C12H12FN5OS
Acta Crystallographica Section E (2017) 73, 2 306-309
a=21.7358(7)Å b=7.3726(3)Å c=8.4487(3)Å
α=90° β=93.0920(10)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(pyridin-2-yl)acetamide
C11H12N6OS
Acta Crystallographica Section E (2018) 74, 5 718-723
a=7.2341(2)Å b=9.3852(2)Å c=9.7971(2)Å
α=95.8200(10)° β=91.1160(10)° γ=105.6820(10)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(pyrazin-2-yl)acetamide
C10H11N7OS
Acta Crystallographica Section E (2018) 74, 5 718-723
a=12.1333(5)Å b=8.1561(3)Å c=12.8442(5)Å
α=90° β=94.307(3)° γ=90°
6-(4-Chlorophenyl)-6a-nitro-6a,6b,8,9,10,12a-hexahydro-6<i>H</i>,7<i>H</i>-spiro[chromeno[3,4-<i>a</i>]indolizine-12,11'-indeno[1,2-<i>b</i>]quinoxaline]
C35H27ClN4O3
Acta Crystallographica Section E (2019) 75, 2 255-259
a=14.18800(10)Å b=23.4450(3)Å c=18.3710(2)Å
α=90° β=104.541(2)° γ=90°
6'-(4-Chlorophenyl)-6a'-nitro-6a',6b',7',9',10',12a'-hexahydro-2<i>H</i>,6'<i>H</i>,8'<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C32H25ClN2O4
Acta Crystallographica Section E (2019) 75, 2 218-222
a=10.6777(4)Å b=11.6095(4)Å c=12.6037(8)Å
α=98.383(3)° β=105.378(3)° γ=115.522(2)°
6'-(4-Methoxyphenyl)-6a'-nitro-6a',6b',7',9',10',12a'-hexahydro-2<i>H</i>,6'<i>H</i>,8'<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C33H28N2O5
Acta Crystallographica Section E (2019) 75, 2 218-222
a=19.8942(2)Å b=13.6097(7)Å c=20.78220(10)Å
α=90° β=107.268(3)° γ=90°
4,4'-{[1,3-Phenylenebis(methylene)]bis(oxy)}bis(3-methoxybenzaldehyde)
C24H22O6
Acta Crystallographica Section E (2019) 75, 6 875-879
a=11.7026(3)Å b=14.6628(4)Å c=12.7512(3)Å
α=90° β=107.863(2)° γ=90°
4,4'-{[(1,4-Phenylenebis(methylene)]bis(oxy)}bis(3-methoxybenzaldehyde)
C24H22O6
Acta Crystallographica Section E (2019) 75, 6 875-879
a=12.6668(5)Å b=7.7470(3)Å c=10.4244(4)Å
α=90° β=102.126(2)° γ=90°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl benzoate
C20H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.75590(10)Å b=16.9258(2)Å c=19.0611(3)Å
α=110.4470(10)° β=96.854(2)° γ=93.3700(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl isobutyrate 0.25-hydrate
C17H21N3O4S,0.25(H2O)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.78020(10)Å b=17.2671(4)Å c=17.3089(4)Å
α=108.2240(10)° β=99.0840(10)° γ=96.7200(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl propionate
C16H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=11.4150(3)Å b=12.4021(3)Å c=13.2305(3)Å
α=71.9820(10)° β=89.8290(10)° γ=83.1140(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl cinnamate chloroform hemisolvate
C22H21N3O4S,0.5(CHCl3)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=10.74270(10)Å b=11.0828(2)Å c=20.8969(3)Å
α=93.1860(10)° β=103.945(4)° γ=98.489(2)°
Bis-(4-dimethylaminopyridinium) bis-(2-nitrobenzoate) trihydrate
2(C7H4NO4),2(C7H11N2),3(H2O)
Acta Crystallographica Section E (2014) 70, 10 221-223
a=7.6163(4)Å b=12.7215(7)Å c=17.3478(9)Å
α=108.2380(10)° β=92.247(2)° γ=101.5120(10)°
6-(4-Chlorophenyl)-6a-nitro-6,6a,6b,7,9,11a-hexahydrospiro[chromeno[3,4':3,4]\ pyrrolo[1,2-<i>c</i>]thiazole-11,11'-indeno[1,2-<i>b</i>]quinoxaline] chloroform solvate
C33H23ClN4O3S1,CHCl3
Acta Crystallographica Section E (2014) 70, 10 o1111-o1112
a=8.983(5)Å b=13.241(5)Å c=14.269(5)Å
α=99.890(5)° β=99.204(5)° γ=105.519(5)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(3-nitrophenyl)acetamide monohydrate
C12H12N6O3S,H2O
Acta Crystallographica Section E (2016) 72, 8 1171-1175
a=7.23260(10)Å b=14.3442(2)Å c=14.0940(3)Å
α=90° β=90° γ=90°
<i>N</i>-(2-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2016) 72, 8 1171-1175
a=7.2528(2)Å b=7.6249(3)Å c=13.0649(4)Å
α=91.410(2)° β=105.924(2)° γ=94.647(2)°
6-Ferrocenyl-6a'-nitro-6',6a',6b',7',9',11a'-hexahydro-2<i>H</i>-\ spiro[acenaphthylene-1,11'-chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazol]-\ 2-one
C34H26FeN2O4S
Acta Crystallographica Section E (2016) 72, 8 1126-1129
a=11.782(5)Å b=16.741(5)Å c=14.147(5)Å
α=90.00° β=98.013(5)° γ=90.00°
6'-(4-Methoxyphenyl)-6a'-nitro-6',6a',6b',7',9',11a'-hexahydro-2<i>H</i>-spiro[acenaphthylene-1,11'-chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazol]-2-one
C31H24N2O5S
Acta Crystallographica Section E (2016) 72, 8 1126-1129
a=11.1123(5)Å b=11.6373(2)Å c=12.4095(3)Å
α=117.8120(10)° β=110.8120(10)° γ=95.4680(10)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(2,4-dimethylphenyl)acetamide
C14H17N5OS
Acta Crystallographica Section E (2017) 73, 7 996-1000
a=23.7716(6)Å b=7.0073(2)Å c=9.0909(2)Å
α=90° β=90.086(2)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(3-methoxyphenyl)acetamide
C13H15N5O2S
Acta Crystallographica Section E (2017) 73, 7 996-1000
a=8.014(5)Å b=8.724(5)Å c=12.068(5)Å
α=106.561(5)° β=97.888(5)° γ=110.461(5)°
4'-(2-Methoxyquinolin-3-yl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',3''-indoline]-1,3,2''-trione
C30H23N3O4
Acta Crystallographica Section E (2015) 71, 12 o1038-o1039
a=10.9058(3)Å b=9.5178(5)Å c=23.8651(6)Å
α=90.00° β=95.378(2)° γ=90.00°
Ethyl 6-methyl-2-sulfanylidene-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C12H14N2O2S2
Acta Crystallographica Section E (2015) 71, 2 o81-o82
a=7.30690(10)Å b=8.32670(10)Å c=11.24610(10)Å
α=90.1090(10)° β=95.1560(10)° γ=101.2760(10)°
4,11-Dihydroxy-13-methyl-1,8-di-<i>p</i>-tolyl-2,9-dithia-13-azadispiro[4.1.4^7^.3^5^]tetradecan-6-one
C26H31NO3S2
Acta Crystallographica Section E (2015) 71, 12 1516-1520
a=10.7160(8)Å b=8.5570(5)Å c=25.6960(3)Å
α=90.00° β=92.374(5)° γ=90.00°
13-Benzyl-4,11-dihydroxy-1,8-bis(4-methylphenyl)-2,9-dithia-13-azadispiro[4.1.4^7^.3^5^]tetradecan-6-one
C32H35NO3S2
Acta Crystallographica Section E (2015) 71, 12 1516-1520
a=9.9803(6)Å b=11.7773(8)Å c=13.6506(14)Å
α=105.524(5)° β=107.215(5)° γ=103.087(4)°
15-(2-Chlorophenyl)-6b-hydroxy-17-methyl-6b,7,16,17-tetrahydro-7,14a-methanonaphtho[1',8':1,2,3]pyrrolo[3',2':8,8<i>a</i>]azuleno[5,6-<i>b</i>]quinolin-14(15<i>H</i>)-one
C34H25ClN2O2
Acta Crystallographica Section E (2015) 71, 12 o1091-o1092
a=11.1328(2)Å b=13.0756(3)Å c=19.0866(4)Å
α=90° β=103.7380(10)° γ=90°
(<i>Z</i>)-1^5^-Bromo-3^2^,3^2^-dimethyl-2^1^-nitro-2^2^,2^3^,2^5^,2^6^,2^7^,2^7a^,3^3a^,3^5^,3^6^,3^6a^-decahydro-2^1^<i>H</i>,6^1^<i>H</i>-4,9-dioxa-2(3,2)-pyrrolizina-6(4,1)-triazola-3(5,6)-furo[2,3-<i>d</i>][1,3]dioxola-1(1,2)-benzenacyclononaphane
C25H29BrN5O7
Acta Crystallographica Section E (2015) 71, 7 827-831
a=9.913(5)Å b=11.414(5)Å c=12.144(5)Å
α=90° β=99.903(5)° γ=90°
(<i>Z</i>)-3^2^,3^2^-Dimethyl-2^7^-nitro-2^5^,2^6^,2^7^,2^7a^,3^3a^,3^5^,3^6^,3^6a^-octahydro-2^1^<i>H</i>,2^3^<i>H</i>,6^1^<i>H</i>-4,9-dioxa-2(5,6)-pyrrolo[1,2-<i>c</i>]thiazola-6(4,1)-triazola-3(5,6)-furo[2,3-<i>d</i>][1,3]dioxola-1(1,2)-benzenacyclononaphane
C24H29N5O7S
Acta Crystallographica Section E (2015) 71, 7 827-831
a=8.756(5)Å b=10.811(5)Å c=13.569(5)Å
α=90° β=101.122(5)° γ=90°
Ethyl 6-chloromethyl-2-oxo-4-(2,3,4-trimethoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C17H21ClN2O6
Acta Crystallographica Section E (2015) 71, 7 821-823
a=9.479(5)Å b=10.080(5)Å c=10.320(5)Å
α=108.552(5)° β=102.886(5)° γ=94.406(5)°
N,6-Dimethyl-4-(methylsulfanyl)-3-nitro-4H-chromen-2-amine
C12H14N2O3S
Acta Crystallographica Section E (2006) 62, 5 o1961-o1963
a=10.5558(5)Å b=17.5031(8)Å c=6.9415(3)Å
α=90.00° β=101.8630(10)° γ=90.00°
1-(3-Nitrophenyl)-5-tosylperhydropyrrolo[3,4-b]pyrrole
C19H21N3O4S
Acta Crystallographica Section E (2006) 62, 5 o2045-o2047
a=7.4456(4)Å b=25.2680(15)Å c=10.0594(6)Å
α=90.00° β=104.2860(10)° γ=90.00°
3-Acetyl-4-furyl-1-methylspiro[pyrrolidine-2.2'-indol]-2'(3'H)-one
C18H18N2O3
Acta Crystallographica Section E (2006) 62, 5 o1964-o1965
a=7.7404(6)Å b=10.0227(7)Å c=20.5622(16)Å
α=90.00° β=90.00° γ=90.00°
3-[α-(4-Methoxyphenyl)-β-(4-chlorophenyl)vinyl]-2-methyl-1-phenylsulfonyl- 1H-indole
C30H24ClNO3S
Acta Crystallographica Section E (2005) 61, 7 o2227-o2229
a=13.6402(9)Å b=10.4097(6)Å c=18.4430(11)Å
α=90.00° β=99.7560(10)° γ=90.00°
3-[α-(4-Methoxyphenyl)-β-phenylvinyl]-2-methyl-1-phenylsulfonyl-1H-indole
C30H25NO3S
Acta Crystallographica Section E (2005) 61, 7 o2221-o2223
a=14.8973(11)Å b=8.9581(7)Å c=18.9941(14)Å
α=90.00° β=97.6580(10)° γ=90.00°
2-(2,5-Dimethylbenzyl)-3-phenylsulfanyl-1-phenylsulfonyl-1H-indole
C29H25NO2S2
Acta Crystallographica Section E (2005) 61, 7 o2224-o2226
a=10.8372(6)Å b=17.2384(10)Å c=12.7220(7)Å
α=90.00° β=90.2690(10)° γ=90.00°
2'-Benzoyl-1'-(4-chlorophenyl)-5',6',7',7a'-tetrahydrospiro[indan- 2,3'(2'H)-1H-pyrrolizidine]-1,3-dione
C28H22ClNO3
Acta Crystallographica Section E (2005) 61, 7 o2158-o2160
a=8.2023(5)Å b=11.7111(7)Å c=25.4650(15)Å
α=102.1020(10)° β=90.0140(10)° γ=103.9490(10)°
[N,N'-Bis(1-{[2-oxido-4-(2-hydroxyethoxy)phenyl]methyl}ethylidene)ethane- 1,2-diamine]copper(II)
C22H26CuN2O6
Acta Crystallographica Section E (2004) 60, 12 m1772-m1774
a=11.8535(7)Å b=8.6424(5)Å c=21.0047(13)Å
α=90.00° β=101.4510(10)° γ=90.00°
3,3-Bis(1H-indol-3-yl)indolin-2-one
C24H17N3O
Acta Crystallographica Section E (2005) 61, 10 o3122-o3123
a=24.0578(12)Å b=10.2342(5)Å c=18.1597(9)Å
α=90.00° β=125.8610(10)° γ=90.00°
{N,N-Bis[3-(phenylysulfanyl)-1-(phenylsulfonyl)indol-2- ylmethyl]amino}acetaldehyde dimethyl acetal
C46H41N3O6S4
Acta Crystallographica Section E (2005) 61, 10 o3205-o3207
a=10.71460(10)Å b=23.89390(10)Å c=16.8782(3)Å
α=90.00° β=91.8460(10)° γ=90.00°
4-[Bis(2-methyl-1H-indol-3-yl)methyl]-1-(4-methoxyphenyl)-3-phenylazetidin- 2-one
C35H31N3O2
Acta Crystallographica Section E (2005) 61, 10 o3386-o3388
a=11.9751(7)Å b=13.4815(8)Å c=17.2114(11)Å
α=90.00° β=91.9780(10)° γ=90.00°
1'-nitro-2'-phenyl-2',3',4',5',6',7'-hexahydro-1H-indole- 3-spiro-3'-1'H-pyrrolizin-2(3H)-one
C20H19N3O3
Acta Crystallographica Section E (2005) 61, 10 o3312-o3314
a=23.8981(15)Å b=7.5886(4)Å c=19.1370(10)Å
α=90.00° β=102.941(2)° γ=90.00°
3-(4-Bromophenyl)-6-(p-tosyl)perhydrothiazolidino[3,4-a]pyrrolo[4,5-c]pyrrole
C21H23BrN2O2S2
Acta Crystallographica Section E (2006) 62, 6 o2146-o2148
a=15.3215(8)Å b=8.0676(4)Å c=17.1663(9)Å
α=90.00° β=100.1190(10)° γ=90.00°
11,18-Diphenoxy-3,26-dioxa-13,16- diazahexacyclo[26.2.2.0^4,9^.0^10,13^.0^16,19^.0^20,25^]dotriaconta- 1(31),4,6,8,20,22,24,28(32),29-nonaene-12,17-dione
C40H34N2O6
Acta Crystallographica Section E (2006) 62, 7 o3082-o3084
a=8.3548(6)Å b=18.1540(13)Å c=22.0663(16)Å
α=90.00° β=90.5280(10)° γ=90.00°
2-Bromo-N-[3-bromo-N-(phenylsulfonyl)indol-2-ylmethyl]aniline
C21H16Br2N2O2S
Acta Crystallographica Section E (2002) 58, 11 o1241-o1243
a=12.3288(9)Å b=8.4100(8)Å c=19.441(2)Å
α=90.00° β=106.296(7)° γ=90.00°
2,6-Bis(N,N'-benzotriazol-1-ylmethyl)pyridine
C19H15N7
Acta Crystallographica Section E (2002) 58, 11 o1190-o1192
a=14.5526(12)Å b=7.9438(9)Å c=14.2666(8)Å
α=90.00° β=93.480(6)° γ=90.00°
6-(4-Methoxyphenyl)-4-phenyl-2-(pyrrolidin-1-yl)nicotinonitrile
C23H21N3O
Acta Crystallographica Section E (2002) 58, 11 o1261-o1263
a=7.9336(5)Å b=10.3841(6)Å c=12.4407(7)Å
α=105.1580(10)° β=104.0770(10)° γ=100.4000(10)°
Cis-3-(p-bromostyryl)-2-methyl-N-(phenylsulfonyl)indole
C23H18BrNO2S
Acta Crystallographica Section E (2002) 58, 11 o1264-o1266
a=10.2443(3)Å b=10.4161(3)Å c=11.4190(3)Å
α=65.0640(10)° β=89.7720(10)° γ=65.7070(10)°
2-methoxybenzaldehyde thiosemicarbazone
C9H11N3OS
Acta Crystallographica Section E (2002) 58, 12 o1336-o1338
a=13.5826(2)Å b=10.6063(2)Å c=14.3260(3)Å
α=90.00° β=90.00° γ=90.00°
6-(4-Chlorophenyl)-4-[4-(dimethylamino)phenyl]-2-(pyrrolidin-1- yl)nicotinonitrile
C24H23ClN4
Acta Crystallographica Section E (2002) 58, 12 o1452-o1454
a=11.14900(10)Å b=13.73300(10)Å c=14.66660(10)Å
α=100.4870(10)° β=93.2400(10)° γ=107.0140(10)°
6,6'-Dichloro-3,3'-(butane-1,4-diyldioxy)diflavone
C34H24Cl2O6
Acta Crystallographica Section E (2002) 58, 12 o1441-o1443
a=5.335(9)Å b=9.242(8)Å c=13.969(9)Å
α=89.270(10)° β=82.680(10)° γ=86.470(10)°
2-Bromo-N-[3-bromo-1-(phenylsulfonyl)indol-2-ylmethyl]-4-methylaniline
C22H18Br2N2O2S
Acta Crystallographica Section E (2003) 59, 2 o177-o179
a=12.436(3)Å b=12.715(3)Å c=16.073(3)Å
α=70.13(3)° β=69.23(3)° γ=66.22(3)°
8-Chloro-4-[1-(phenylsulfonyl)indol-3-yl]-3a,4,5,9b-tetrahydro-3H- cyclopenta[c]quinoline
C26H21ClN2O2S
Acta Crystallographica Section E (2003) 59, 1 o49-o51
a=15.0064(2)Å b=9.4052(2)Å c=15.7077(2)Å
α=90.00° β=91.0930(10)° γ=90.00°
2-Hydroxy-2-methyl-3-benzoylchromene
C17H14O3
Acta Crystallographica Section E (2003) 59, 3 o266-o268
a=5.691(4)Å b=6.902(3)Å c=34.044(2)Å
α=90.00° β=90.00° γ=90.00°
5-Amino-4-(4-dimethylaminophenyl)-2-(4-methoxyphenyl)-7-(pyrrolidin-1-yl)- 1,6-naphthyridine-8-carbonitrile
C28H28N6O
Acta Crystallographica Section E (2003) 59, 2 o200-o202
a=10.671(2)Å b=10.9740(10)Å c=11.826(2)Å
α=82.820(10)° β=64.040(10)° γ=78.320(10)°
2-cyano-3-dimethylamino-N-(2,5-methylphenyl)acrylamide
C14H17N3O
Acta Crystallographica Section E (2003) 59, 3 o353-o355
a=9.9315(2)Å b=11.8940(4)Å c=11.3979(4)Å
α=90.00° β=97.079(14)° γ=90.00°
2-Methoxy-4-acetamido-5-(3'-phenylthio indol-2-oyl)benzoic acid
C25H20N2O5S
Acta Crystallographica Section E (2003) 59, 5 o718-o720
a=10.8499(2)Å b=10.5171(2)Å c=19.0168(3)Å
α=90.00° β=92.1040(10)° γ=90.00°
3,3,6,6-Tetramethyl-9-(4-pyridyl)-3,4,6,7,9,10-hexahydro- 1,8(2H,5H)-acridinedione monohydrate
C22H26N2O2,H2O
Acta Crystallographica Section E (2003) 59, 5 o659-o661
a=9.1333(5)Å b=9.8999(5)Å c=12.0435(7)Å
α=74.8760(10)° β=81.7050(10)° γ=73.1370(10)°
1,2-Bis[1-phenylsulfonyl-3-(phenylthio)indol-2-yl]ethene
C42H30N2O4S4
Acta Crystallographica Section E (2003) 59, 1 o99-o101
a=9.2920(2)Å b=9.5524(3)Å c=11.3921(3)Å
α=67.3790(10)° β=72.8210(10)° γ=74.5890(10)°
5,5'-dimethyl-2-(4-methylphenylaminocarbomethyl)-1,3-cyclohexanedione
C17H21NO3
Acta Crystallographica Section E (2003) 59, 3 o261-o262
a=10.12390(10)Å b=5.83660(10)Å c=26.91760(10)Å
α=90.00° β=97.4030(10)° γ=90.00°
10-[2-(4-acetylpiperzain-1-yl)ethyl]-9-(4-chlorophenyl)-3,3,6,6-tetramethyl- 3,4,6,7,9,10-hexahydro-2H,5H-acridine-1,8-dione
C31H40ClN3O3
Acta Crystallographica Section E (2003) 59, 5 o696-o698
a=10.3624(6)Å b=21.4915(12)Å c=13.5314(8)Å
α=90.00° β=101.4920(10)° γ=90.00°
3-Acetyl-2-hydroxy-2-methylchromene
C12H12O3
Acta Crystallographica Section E (2003) 59, 5 o591-o593
a=7.574(2)Å b=8.672(2)Å c=8.789(3)Å
α=106.32(3)° β=110.99(3)° γ=93.28(3)°
2-[2-(4-Ethoxy-5-methoxy-2-nitrophenyl)vinyl]-1H-indole
C19H18N2O4
Acta Crystallographica Section E (2003) 59, 5 o672-o674
a=7.5949(4)Å b=10.0887(6)Å c=11.5777(7)Å
α=85.2980(10)° β=76.9240(10)° γ=86.1660(10)°
1,4-Bis{2-hydroxy-3-[N-(2-hydroxyethyl)imino]-5-methylbenzyl}piperazine
C26H36N4O4
Acta Crystallographica Section E (2003) 59, 1 o83-o85
a=9.7575(2)Å b=13.8091(3)Å c=18.42700(10)Å
α=90.00° β=99.9640(10)° γ=90.00°
Phyllanthin from the plant phyllanthus amarus
C24H34O6
Acta Crystallographica Section E (2003) 59, 2 o203-o205
a=22.6091(7)Å b=5.3506(2)Å c=11.0871(4)Å
α=90.00° β=117.3280(10)° γ=90.00°
N,N-Dimethyl-N'-phenylformamidinium perchlorate
C9H13N2ClO4
Acta Crystallographica Section E (2003) 59, 5 o662-o664
a=7.8382(2)Å b=17.5688(6)Å c=9.1123(2)Å
α=90.00° β=113.2690(10)° γ=90.00°
Spiro- [2 -3'] oxindole - spiro -[3- 3"] oxindole - 4[p-methyl benzydy] pyrolidizine.
C29H25N3O3
Acta Crystallographica Section E (2003) 59, 10 o1458-o1460
a=9.7632(6)Å b=10.3841(7)Å c=11.6874(8)Å
α=99.7350(10)° β=96.4800(10)° γ=98.8920(10)°
30,31-Dimethyl-3,26-dioxa-11,18- diazapentacyclo[26.4.0.0^4,9^.0^12,17^.0^20,25^]dotriconta- 1(32),4,6,8,12,14,16,20,22,24,28,30-dodecaene-10,19-dione
C30H26N2O4
Acta Crystallographica Section E (2003) 59, 9 o1429-o1431
a=15.5767(9)Å b=15.7746(9)Å c=20.5721(12)Å
α=90.00° β=102.5410(10)° γ=90.00°
9, 17-Dioxa-1,3-dithiatetracyclo[18. 2. 2. 2^23, 24^. 1^25^] heptacosan-5, 7, 11,13, 15 (25), 18, 20, 23, 26 nonene
C23H22O2S2
Acta Crystallographica Section E (2003) 59, 11 o1677-o1679
a=9.995(5)Å b=10.372(7)Å c=10.508(5)Å
α=101.84(5)° β=91.14(5)° γ=109.01(5)°
2'-Benzoyl-1',2,2',3,4',5',6',6a'-octahydro-1H-indan-2-spiro-3'- (3'H-pyrrolizine)-1'-spiro-3''-1H-indoline-1,2'',3-trione
C29H22N2O4
Acta Crystallographica Section E (2003) 59, 10 o1559-o1561
a=13.1419(10)Å b=12.5844(9)Å c=14.0110(11)Å
α=90.00° β=100.601(2)° γ=90.00°
2'-(p-Methoxybenzoyl)-1',2,2',3,5',6',7',7a'-octahydro-1H-indan-2-spiro-3'- (3'H-pyrrolizine)-1'-spiro-3''-1H-indoline-1,2'',3-trione
C30H24N2O5
Acta Crystallographica Section E (2003) 59, 11 o1783-o1785
a=11.4931(8)Å b=13.6374(9)Å c=15.5377(10)Å
α=90.00° β=96.3510(10)° γ=90.00°
C23H24N2O3
C23H24N2O3
Acta Crystallographica, Section E: Structure Reports Online (2003) 59, 10 o1438-o1440
a=6.3317(5)Å b=11.5470(8)Å c=14.1402(10)Å
α=72.2400(10)° β=77.3660(10)° γ=77.7730(10)°
C-halogen...π interaction: 4-Chloro-2-(9-ethylcarbazol-3-yl)quinoline-1(2H)- carbaldehyde.
C24H19ClN2O
Acta Crystallographica Section E (2003) 59, 10 o1564-o1566
a=9.4147(8)Å b=9.6714(8)Å c=11.1245(9)Å
α=85.3360(10)° β=70.2350(10)° γ=84.351(2)°
C31H28N2O3
C31H28N2O3
Acta Crystallographica Section E (2003) 59, 11 o1680-o1681
a=14.3186(11)Å b=9.6801(7)Å c=17.9616(13)Å
α=90.00° β=91.1900(10)° γ=90.00°
1,2,3,4-Tetrahydro-4'-furfuryl-1'-methylnaphthene-2-spiro-3'-pyrrolidine-2'- spiro-1''-acenaphthene-1,2''-dione
C29H23NO3
Acta Crystallographica Section E (2003) 59, 12 o1875-o1877
a=11.9109(7)Å b=11.3292(7)Å c=17.3573(10)Å
α=90.00° β=103.9930(10)° γ=90.00°
5''-Benzylidene-1'-methyl-4'-phenylindole-3-spiro-2'-pyrrolidine-3'-spiro-3''- piperidine-2(3H),4''-dione
C30H29N3O2
Acta Crystallographica Section E (2003) 59, 12 o1878-o1880
a=10.6889(7)Å b=18.9025(12)Å c=12.5270(8)Å
α=90.00° β=95.2830(10)° γ=90.00°
4'-(4-Methoxybenzoyl)-1'-methyl-acenaphthene-1-spiro-2'-pyrrolidine- 3'-spiro-3''-1H-indole-2,2''(1H,3''H)-dione hemihydrate
C31H24N2O4,0.5H2O
Acta Crystallographica Section E (2004) 60, 6 o1003-o1005
a=25.647(2)Å b=10.0538(9)Å c=21.0859(18)Å
α=90.00° β=111.933(2)° γ=90.00°
Ethyl 2,2''-dioxo-2,3,5,6,7,7a-hexahydroacenaphthene- 1-spiro-3'-1'H-pyrrolizine-2'spiro-1''-acenaphthene-1-carboxylate
C32H25NO4
Acta Crystallographica Section E (2005) 61, 7 o2267-o2269
a=14.8348(12)Å b=11.1902(9)Å c=16.0909(13)Å
α=90.00° β=112.4790(10)° γ=90.00°
2-Ethyl 3,4-dimethyl 4'-methylbiphenyl-2,3,4-tricarboxylate
C20H20O6
Acta Crystallographica Section E (2005) 61, 10 o3339-o3341
a=6.7650(6)Å b=23.8952(19)Å c=12.0094(10)Å
α=90.00° β=105.6700(10)° γ=90.00°
Methyl 11,2,3,3a-5a-hydroxy-1-methyl-10-oxo-4-phenyl 10H-indeno[1,2-b]furo[3,4-b]pyrrole-3a-carboxylate
C22H21NO5
Acta Crystallographica Section E (2005) 61, 10 o3383-o3385
a=8.6216(5)Å b=10.3055(6)Å c=11.7758(6)Å
α=79.4620(10)° β=79.3770(10)° γ=68.8760(10)°
3-Benzylidene-3',7'-diphenylcyclohexanespiro-6'-(perhydro-2-thiapyrrolizine)- 5'-spiro-3''-1H-indole-2,2''-dione
C37H32N2O2S
Acta Crystallographica Section E (2006) 62, 6 o2259-o2260
a=10.0312(6)Å b=20.8599(13)Å c=14.1305(8)Å
α=90.00° β=100.9730(10)° γ=90.00°
2-(p-Bromophenyl)-5-(benzenesulfonyl)perhydrothiazolidine[3,4-a]pyrrolo[4,5-c] pyrrole
C20H21BrN2O2S2
Acta Crystallographica Section E (2006) 62, 6 o2429-o2431
a=10.5926(6)Å b=11.4144(6)Å c=16.6896(9)Å
α=90.00° β=94.1020(10)° γ=90.00°
Acenapthene-2-spiro-5'-perhydrodipyrrole[1,2-a;2',1'-c]pyrazine-6'- spiro-2''-acenapthene-1,1''-dione
C32H26N2O2
Acta Crystallographica Section E (2006) 62, 6 o2432-o2434
a=8.8721(7)Å b=10.7042(8)Å c=14.2846(11)Å
α=109.4180(10)° β=100.5840(10)° γ=102.4470(10)°
6a,14a-cis-6,6a,7,14a-Tetrahydrochromeno[4',3':3,4]pyrano[3,2-c]coumarin
C19H14O4
Acta Crystallographica Section E (2003) 59, 9 o1395-o1397
a=12.22520(10)Å b=16.3351(3)Å c=15.3425(3)Å
α=90.00° β=109.2070(10)° γ=90.00°
8a,13b-cis-8,8,13-Trimethyl-11-phenyl-8,8a,9,13b- tetrahydropyrazolo[3'',4''-b']thiapyrano[5',4':3,4]pyrano[5,6-c]coumarin
C25H22N2O3S
Acta Crystallographica Section E (2004) 60, 11 o2155-o2156
a=10.1017(11)Å b=10.2760(12)Å c=20.187(2)Å
α=90.00° β=95.278(2)° γ=90.00°